AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

BTI · NYSE · Tobacco

British American Tobacco (ADR) (BTI)

Sells cigarettes alongside Vuse vapour, glo heated tobacco, and Velo oral nicotine.

$55.97

vs last close+0.21 (+0.39%)

In millions of USD, except per-share figures · converted from GBP at the latest rate

In millions	Q4 FY20Dec 2020	Q2 FY21Jun 2021	Q4 FY21Dec 2021	Q2 FY22Jun 2022	Q4 FY22Dec 2022	Q2 FY23Jun 2023	Q4 FY23Dec 2023	Q2 FY24Jun 2024	Q4 FY24Dec 2024	Q2 FY25Jun 2025	Q4 FY25Dec 2025	Q2 FY26Jun 2026
Revenue	18,019	16,244	18,024	17,170	19,728	17,934	18,469	16,465	18,048	16,103	18,067	16,445
Cost of revenue	3,266	2,835	3,298	2,873	3,537	2,994	3,532	2,887	3,031	2,643	2,995	6,731
Gross profit	14,753	13,409	14,726	14,298	16,191	14,939	14,937	13,577	15,017	13,460	15,072	9,714
	8,031	6,583	7,410	4,567	7,058	7,021	43,871	7,896	17,048	6,697	8,496	3,430
Research & development	227	189	216	200	231	259	286	224	283	232	232	0
	3,320	1,724	3,357	1,708	3,401	1,853	3,289	1,835	3,437	1,952	3,652	3,556
Selling & marketing	1,462	0	1,657	0	1,548	0	1,537	0	1,482	0	1,457	0
General & administrative	1,857	0	1,700	0	1,853	0	1,752	1,835	1,955	0	2,195	0
Other expenses	195	136	125	56	3,426	4,909	40,297	5,837	13,328	4,512	4,612	−126
Operating income	7,832	6,754	7,923	4,907	9,133	7,919	−28,934	5,681	−2,031	6,763	6,575	6,284
	1,296	−1,246	−1,195	−823	−777	−843	−905	1,791	−720	674	−858	−837
Interest income	1,278	977	939	502	27	113	135	318	318	0	131	114
Interest expense	0	0	0	1,461	1,071	1,205	1,377	2,404	939	1,019	1,109	1,112
Other non-operating income	−2,392	250	200	446	−1,061	4	−37,736	−5	−4,707	−7	−692	0
Income before tax	5,444	5,849	6,376	4,084	8,356	7,075	−29,839	7,472	−2,751	7,437	5,717	5,446
Income tax expense	1,406	1,408	1,513	1,498	1,808	1,692	−5,524	1,389	−913	1,346	1,448	1,108
Net income from continuing operations	3,805	4,131	4,620	2,319	6,548	4,998	−24,315	6,083	−1,839	6,091	4,270	4,339
Other adjustments	232	311	227	0	0	0	0	0	0	0	0	0
Net income	3,927	4,336	4,722	2,480	6,414	5,282	−24,451	5,993	−1,900	6,020	4,339	4,288
EPS, basic	$1.72	$1.89	$2.07	$1.08	$2.83	$2.36	−$10.98	$2.67	−$0.88	$2.72	$1.93	$1.96
EPS, diluted	$1.71	$1.89	$2.05	$1.08	$2.82	$2.35	−$10.98	$2.67	−$0.88	$2.72	$1.93	$1.95
Weighted average shares, basic	2,286	2,287	2,288	2,262	2,254	2,229	2,230	2,232	2,202	2,205	2,193	2,165
Weighted average shares, diluted	2,296	2,296	2,298	2,273	2,261	2,237	2,230	2,232	2,202	2,205	2,193	2,176
EBITDA	7,070	7,172	7,867	5,649	10,455	8,563	9,007	7,848	2,475	8,264	8,556	8,117
Depreciation & amortization	762	636	738	704	262	640	205	2,161	1,976	1,494	1,289	1,833
EBIT	6,308	6,535	7,129	5,353	10,194	7,923	8,802	5,687	499	6,770	7,268	6,284